Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 149

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 149
---
 actions or agree to any undertakings that would limit Alcon’s or its controlled affiliates’ freedom of action with respect to, or their ability to retain, or impose obligations on Alcon’s or its controlled affiliates’ future operation with respect to any asset, product, product line or business of Alcon, STAAR, or any of their respective controlled affiliates (each of foregoing clauses (i)–(iii), a “Remedy Action”); provided, however, that, (A) Alcon is not required to sell or divest any asset, product, product line, or business of Alcon, STAAR, or any of their respective affiliates, (B) Alcon is not required to take any Remedy Action that would, individually or in the aggregate, reasonably be expected to result in a greater than $50 million reduction in the aggregate amount of reasonably projected LASIK and ICL sales revenue of Alcon and its controlled affiliates, including STAAR and its subsidiaries, taken as a whole, for the twelve (12)-month period following Closing, and (C) STAAR is only required to take or commit to take a Remedy Action if such Remedy Action is binding on STAAR only in the event the Closing occurs. Further, under the Merger Agreement, Alcon, Merger Sub, and STAAR agreed to, and to cause their respective affiliates to:

| • |     | promptly, but in no event later than twenty (20) business days after the date of the Merger Agreement,                                                                                                                                  
 unless otherwise agreed by the parties, make an appropriate filing of all Notification and Report Forms with the U.S. Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice as required by the HSR Act; |

-91-

| • |     | as promptly as reasonably practicable, but in no event later than thirty-five (35) business days after the                                             
 date of the Merger Agreement, submit all other filings or notifications (or drafts thereof) in connection with any other required regulatory approval; |

| • |     | give each other prompt notice of the making or commencement of any notice, communication, request, inquiry,                                                                                                                                       
 investigation, action or legal proceeding brought, or threatened to be brought, by a governmental body, or by a third party before any governmental body, in each case, with respect to the transactions contemplated by the Merger Agreement and 
 relating to any antitrust or foreign investment law;                                                                                                                                                                                              |

| • |     | keep each